DETECTION OF IMMUNOPHENOTYPIC ABNORMALITIES IN PARAFFIN-EMBEDDED B-LINEAGE NON-HODGKINS-LYMPHOMAS

被引:45
作者
GELB, AB
ROUSE, RV
DORFMAN, RF
WARNKE, RA
机构
[1] STANFORD UNIV,MED CTR,SCH MED,DEPT PATHOL,STANFORD,CA 94305
[2] UNIV CALIF SAN FRANCISCO,DEPT LAB MED,SAN FRANCISCO,CA 94143
[3] VET AFFAIRS MED CTR,PALO ALTO,CA 94304
关键词
NON-HODGKINS LYMPHOMA; IMMUNOHISTOCHEMISTRY; ANTIBODY; BCL-2;
D O I
10.1093/ajcp/102.6.825
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
The authors analyzed the frequency of immunophenotypic abnormalities in 1,474 eases of routinely fixed, paraffin-embedded B-lineage non-Hodgkin's lymphomas. B-lineage was determined by immunoreactivity for CD20 (L26, 92%); CD45RA (4KB5, an additional 3%) or immunoglobulin (Ig) light chain restriction (remaining 5%). CD35RA was found to be especially helpful on Bouin's-fixed or decalcified tissue and Ig staining was most helpful in plasmacytoid lesions. Coexpression of the T-cell marker CD43 (Leu-22) was the most common immunophenotypic abnormality, seen in 60% of mantle cell lymphomas (MCL), 39% of CLL/small lymphocytic lymphomas, 16% of diffuse large cell lymphomas (DLCL), but only 5% of follicular lymphomas (FL). Antibodies to CD45RO (A6 and UCHL1) and CD3 (polyclonal) were useful in distinguishing infiltrating T cells from B cells coexpressing CD43. Ig light chain restriction was the next commonest immunophenotypic abnormality, which was identified in 67% of plasmacytoid diffuse small cell lymphomas, 43% of MCLs, 35% of monocytoid B-cell lymphomas and 28% of FLs. Overexpression of bcl-2 oncogenic protein was observed in 71% of FLs (n = 96), but not in a control group of reactive follicular hyperplasias (n = 34). Combining two criteria increased the sensitivity of immunodiagnosis in certain circumstances.
引用
收藏
页码:825 / 834
页数:10
相关论文
共 47 条
[1]  
ANDERSON C, 1991, MODERN PATHOL, V4, P358
[2]  
[Anonymous], 1982, CANCER, V49, P2112
[3]  
ARBER DA, 1993, APPLIED IMMUNOHISTOC, V1, P88
[4]   MANTLE CELL LYMPHOMA - A PROPOSAL FOR UNIFICATION OF MORPHOLOGICAL, IMMUNOLOGICAL, AND MOLECULAR-DATA [J].
BANKS, PM ;
CHAN, J ;
CLEARY, ML ;
DELSOL, G ;
DEWOLFPEETERS, C ;
GATTER, K ;
GROGAN, TM ;
HARRIS, NL ;
ISAACSON, PG ;
JAFFE, ES ;
MASON, D ;
PILERI, S ;
RALFKIAER, E ;
STEIN, H ;
WARNKE, RA .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1992, 16 (07) :637-640
[5]  
Beverley P C, 1992, Semin Immunol, V4, P35
[6]   ADVANTAGES OF DETECTING MONOCLONAL-ANTIBODY BINDING TO TISSUE-SECTIONS WITH BIOTIN AND AVIDIN REAGENTS IN COPLIN JARS [J].
BINDL, JM ;
WARNKE, RA .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1986, 85 (04) :490-493
[7]  
CARTUN RW, 1987, AM J PATHOL, V129, P415
[8]   MULTIMARKER IMMUNOHISTOCHEMICAL STAINING OF CALGRANULINS, CHLOROACETATE ESTERASE, AND S100 FOR SIMULTANEOUS DEMONSTRATION OF INFLAMMATORY CELLS ON PARAFFIN SECTIONS [J].
CHILOSI, M ;
MOMBELLO, A ;
MONTAGNA, L ;
BENEDETTI, A ;
LESTANI, M ;
SEMENZATO, G ;
MENESTRINA, F .
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 1990, 38 (11) :1669-1675
[9]  
CONTOS MJ, 1992, MODERN PATHOL, V5, P631
[10]  
GAULARD P, 1992, AM J PATHOL, V140, P1089